TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32369631

Group type: EXPERIMENTAL
Intervention: Prednisone Therapy
Number of subjects: 0
Study: 33544937

Group type: EXPERIMENTAL
Intervention: Strategy A - Education delivered directly to families
Number of subjects: 1426

Group type: EXPERIMENTAL
Intervention: Strategy B - Education delivered first to teachers, then to families
Number of subjects: 1426

Group type: EXPERIMENTAL
Intervention: Strategy C - Education delivered only to healthcare coordinators, then to teachers and families
Number of subjects: 1426

Group type: COMPARATOR
Intervention: Control group - No intervention
Number of subjects: 1426
Study: 32886447

Group type: COMPARATOR
Intervention: Pregabalin (PGB) monotherapy (150 mg twice daily)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Combined Pregabalin (PGB) (150 mg twice daily) and Milnacipran (MLN) (50 mg twice daily)
Number of subjects: 58
Study: 32195927

Group type: EXPERIMENTAL
Intervention: Daily educational text messages on diabetes and reminders for 6 months
Number of subjects: 216

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 216
Study: 34559571

Group type: EXPERIMENTAL
Intervention: Symptom management journal at the start of SACT
Number of subjects: 64

Group type: COMPARATOR
Intervention: Symptom management journal after completing two cycles of SACT
Number of subjects: 64
Study: 32182123

Group type: EXPERIMENTAL
Intervention: Canagliflozin (600 mg)
Number of subjects: 10
Study: 36181564

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (no SDD)
Number of subjects: 118
Study: 33482910

Group type: EXPERIMENTAL
Intervention: PVP-I-ALC (povidone-iodine-alcohol)
Number of subjects: 16

Group type: COMPARATOR
Intervention: CHG-ALC (chlorhexidine-alcohol)
Number of subjects: 16
Study: 32838676

Group type: EXPERIMENTAL
Intervention: Whole Health Action Management (WHAM)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Care as usual (control)
Number of subjects: 139
Study: 35197356

Group type: EXPERIMENTAL
Intervention: Volatile sedatives
Number of subjects: 96

Group type: COMPARATOR
Intervention: Intravenous sedatives
Number of subjects: 96
Study: 33971386

Group type: EXPERIMENTAL
Intervention: Neratinib
Number of subjects: 1631

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1631
Study: 616173446

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 177

Group type: COMPARATOR
Intervention: Regular recommended HF therapy (including maximized beta-blockade)
Number of subjects: 177
Study: 35022014

Group type: EXPERIMENTAL
Intervention: Memantine (10 mg twice daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sertraline (100 mg daily initially followed by 200 mg daily after week 4)
Number of subjects: 70
Study: 33815503

Group type: EXPERIMENTAL
Intervention: One-session treatment group with BioRoot RCS
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Two-session treatment group with BioRoot RCS
Number of subjects: 12
Study: 32466128

Group type: EXPERIMENTAL
Intervention: Socioeconomic and psychosocial factors supporting sustainable agriculture practices (SAPs)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Theory of planned behavior (TPB) dimensions
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Policy measures supporting socioeconomic and psychosocial factors
Number of subjects: 300
Study: 34487844

Group type: EXPERIMENTAL
Intervention: Safflower oil (8 g daily for 12 weeks)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 34959944

Group type: EXPERIMENTAL
Intervention: Probiotic powder containing Lactobacillus acidophilus, Bifidobacterium lactis, and S. salivarius K12
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo-control powder
Number of subjects: 25
Study: 34282608

Group type: EXPERIMENTAL
Intervention: Tight-fitting method with a clip
Number of subjects: 30

Group type: COMPARATOR
Intervention: General-fitting method
Number of subjects: 30
Study: 32353535

Group type: EXPERIMENTAL
Intervention: High-Definition Chromoendoscopy (HD-CE) with indigo carmine, collection of 32 random biopsies, and targeted biopsies or polypectomies
Number of subjects: 305

Group type: COMPARATOR
Intervention: High-Definition White Light Endoscopy (HD-WLE), collection of 32 random biopsies, and targeted biopsies or polypectomies
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: High-Definition Chromoendoscopy (HD-CE)
Number of subjects: 305

Group type: COMPARATOR
Intervention: High-Definition White Light Endoscopy (HD-WLE)
Number of subjects: 305
Study: 35108029

Group type: EXPERIMENTAL
Intervention: Intelligent Vacuum-Assisted Biopsy (VAB)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Imaging after NST
Number of subjects: 318

Group type: COMPARATOR
Intervention: VAB alone
Number of subjects: 318

Group type: COMPARATOR
Intervention: Combinations of imaging and VAB
Number of subjects: 318
Study: 34747917

Group type: EXPERIMENTAL
Intervention: Topical diltiazem (diltiazem group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo gel (placebo group)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 35852267

Group type: EXPERIMENTAL
Intervention: Methylergonovine plus oxytocin
Number of subjects: 160

Group type: COMPARATOR
Intervention: Oxytocin alone
Number of subjects: 160
Study: 33793289

Group type: EXPERIMENTAL
Intervention: Burnout intervention
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Work culture prioritizing person-centered care
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Robust management skills and practices
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Opportunities for professional development and self-care
Number of subjects: 40
Study: 32197107

Group type: EXPERIMENTAL
Intervention: Two-dose primary series (days 1 and 91)
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: One primary dose (day 1)
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: One primary dose plus booster (days 1 and 365)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1800
Study: 35545057

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin treatment for 6 weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 41
Study: 32706261

Group type: EXPERIMENTAL
Intervention: MitoQ (80 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 35001842

Group type: EXPERIMENTAL
Intervention: Aerobic exercise only
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Imaginal exposure only
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Imaginal exposure plus exercise
Number of subjects: 72

Group type: COMPARATOR
Intervention: No exercise/no exposure therapy (control)
Number of subjects: 72
Study: 34020452

Group type: EXPERIMENTAL
Intervention: Ready-to-use supplementary food (RUSF)
Number of subjects: 2691

Group type: EXPERIMENTAL
Intervention: Corn soy whey blend with fortified vegetable oil (CSWB w/oil)
Number of subjects: 2691

Group type: EXPERIMENTAL
Intervention: Super Cereal Plus with amylase (SC + A)
Number of subjects: 2691

Group type: COMPARATOR
Intervention: Corn Soy Blend Plus with fortified vegetable oil (CSB+ w/oil)
Number of subjects: 2691
Study: 34218509

Group type: EXPERIMENTAL
Intervention: High n-3 plus low n-6 dietary intervention (H3-L6)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control diet (CD)
Number of subjects: 82
Study: 34976106

Group type: EXPERIMENTAL
Intervention: Path-type health education
Number of subjects: 162

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 162
Study: 33167882

Group type: EXPERIMENTAL
Intervention: $25 gift card at each follow-up visit
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current standard of care
Number of subjects: 0
Study: 36154311

Group type: EXPERIMENTAL
Intervention: e-learning short-term intervention delivered via app
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: e-learning short-term intervention delivered via email
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34420765

Group type: EXPERIMENTAL
Intervention: Adequate infant feeding support
Number of subjects: 997

Group type: COMPARATOR
Intervention: Inadequate infant feeding support
Number of subjects: 997
Study: 32207413

Group type: EXPERIMENTAL
Intervention: Eccentric muscle energy technique with cervical segmental mobilisation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Static stretching exercises with cervical segmental mobilisation
Number of subjects: 40
Study: 34279976

Group type: EXPERIMENTAL
Intervention: Person-Centered Care Planning (PCCP)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Medication adherence
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Medication management
Number of subjects: 22
Study: 34616808

Group type: EXPERIMENTAL
Intervention: Probiotics (2 g) added to a low FODMAP diet
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo added to a low FODMAP diet
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups (Probiotics and Placebo)
Number of subjects: 100
Study: 616118527

Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 2771

Group type: EXPERIMENTAL
Intervention: Statin users (females)
Number of subjects: 2771
Study: 34737837

Group type: EXPERIMENTAL
Intervention: Bloodletting at Shaoshang (LU11) and Shangyang (LI1) acupuncture points, 2-3 ml volume, repeated three times (once daily)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Bloodletting at Shaoshang (LU11) and Shangyang (LI1) acupuncture points
Number of subjects: 62
Study: 33284838

Group type: EXPERIMENTAL
Intervention: Phonemic cues intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 34558993

Group type: EXPERIMENTAL
Intervention: Self-resisted neck strength training (3 times weekly for 8 weeks)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (normal practice without neck-specific exercises)
Number of subjects: 28
Study: 33185628

Group type: EXPERIMENTAL
Intervention: Amifampridine (3,4-diaminopyridine [3,4-DAP]) at a recommended dose of 80 mg a day, divided 3 or 4 times a day.
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Amifampridine (3,4-DAP) for pediatric patients.
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Amifampridine (3,4-DAP)
Number of subjects: 344
Study: 36011588

Group type: EXPERIMENTAL
Intervention: Yi Jin Jing and resistance training (YR)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 90
Study: 35618168

Group type: EXPERIMENTAL
Intervention: 10-Hz repetitive transcranial magnetic stimulation (rTMS) over left prefrontal cortex (PFC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: intermittent theta-burst stimulation (iTBS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: sham stimulation
Number of subjects: 40
Study: 34213717

Group type: EXPERIMENTAL
Intervention: Parent training (PT)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Psychoeducation (PEP)
Number of subjects: 169
Study: 32203453

Group type: EXPERIMENTAL
Intervention: Luseogliflozin 2.5 mg daily (or up to 5 mg daily)
Number of subjects: 941
Study: 36482613

Group type: EXPERIMENTAL
Intervention: Educational music training
Number of subjects: 70
Study: 33847047

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 5669

Group type: COMPARATOR
Intervention: ramipril (ACE inhibitor)
Number of subjects: 5669
Study: 32103567

Group type: EXPERIMENTAL
Intervention: Daily surveys assessing PTSD symptoms
Number of subjects: 20
Study: 35989622

Group type: EXPERIMENTAL
Intervention: Online-based health education and free access to hand cleansing and hand care products
Number of subjects: 302

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 302
Study: 34074291

Group type: EXPERIMENTAL
Intervention: Percutaneous periarticular injection including methylprednisolone, ropivacaine, and epinephrine at 1 day after surgery
Number of subjects: 44

Group type: COMPARATOR
Intervention: No additional injection (control group)
Number of subjects: 44
Study: 35772665

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo (platinum-based chemotherapy)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Olaparib (platinum-based chemotherapy)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo (non-platinum-based chemotherapy)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Olaparib (non-platinum-based chemotherapy)
Number of subjects: 147
Study: 33759075

Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency (25OHD deficiency)
Number of subjects: 1812

Group type: EXPERIMENTAL
Intervention: Vitamin D inadequacy (25OHD inadequacy)
Number of subjects: 1812
Study: 35829765

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 160

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 160
Study: 33774848

Group type: EXPERIMENTAL
Intervention: Metformin extended-release 1500 mg daily for 26 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Matched placebo for 26 weeks
Number of subjects: 40
Study: 32053828

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 36
Study: 35044581

Group type: EXPERIMENTAL
Intervention: ICE-guided ablation
Number of subjects: 91

Group type: COMPARATOR
Intervention: Fluoroscopy-only ablation
Number of subjects: 91
Study: 32866344

Group type: EXPERIMENTAL
Intervention: Multicolored 3D-printed teeth models
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard plastic teeth (control)
Number of subjects: 0
Study: 33501595

Group type: EXPERIMENTAL
Intervention: JWH‐018 (75μg/kg bodyweight, average dose 5.52 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 33837996

Group type: EXPERIMENTAL
Intervention: Surgical counts performed between 8:00 a.m. to 12:00 a.m.
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Emergency operations
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Prolonged procedures
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Addition of surgical items
Number of subjects: 70
Study: 35083837

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise
Number of subjects: 56

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 56
Study: 33538250

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: TOs in left main and/or left anterior descending artery
Number of subjects: 460
Study: 33877876

Group type: EXPERIMENTAL
Intervention: Empagliflozin as an add-on therapy
Number of subjects: 0
Study: 33033962

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ivabradine co-administered with ketoconazole (CYP3A4 inhibitor)
Number of subjects: 0
Study: 35460449

Group type: EXPERIMENTAL
Intervention: Guided self-help family-based treatment (GSH-FBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Family-based treatment delivered via videoconferencing (FBT-V)
Number of subjects: 0
Study: 33130890

Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ) chemotherapy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 98
Study: 35274413

Group type: EXPERIMENTAL
Intervention: Subcutaneous interferon beta‐1a (sc IFN β‐1a) 44 μg once or three times weekly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35985024

Group type: EXPERIMENTAL
Intervention: Experimental group (n = 7) - attended training course, Alzheimer Café, self-help group, in-home visits from volunteer and professional nurse
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (n = 7) - attended standard intervention
Number of subjects: 14
Study: 33070244

Group type: EXPERIMENTAL
Intervention: Coping and Promoting Strength (CAPS)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Information-monitoring (IM)
Number of subjects: 113
Study: 34793724

Group type: EXPERIMENTAL
Intervention: Breastfeeding exclusivity group with low initial probability (n = 60, 49%)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Breastfeeding exclusivity group with greater initial probability (n = 62, 51%)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: PIM group with greater probability of endorsing PIM (n = 41, 34%)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: PIM group with low probability of endorsing PIM (n = 81, 66%)
Number of subjects: 122
Study: 32024852

Group type: EXPERIMENTAL
Intervention: NaHCO3 (up to 100 mg·kg‐1)
Number of subjects: 51
Study: 33576936

Group type: EXPERIMENTAL
Intervention: 165 μg PEGylated exenatide
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 330 μg PEGylated exenatide
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 660 μg PEGylated exenatide
Number of subjects: 36
Study: 32618165

Group type: EXPERIMENTAL
Intervention: Ultrasonic scaler with ozonated water (Ozonline®)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ultrasonic scaler (Control)
Number of subjects: 10
Study: 35365535

Group type: EXPERIMENTAL
Intervention: Proactive TDM combined PK dashboard-driven infliximab dosing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (SOC) infliximab therapy
Number of subjects: 0
Study: 32332458

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg/d for 15 days)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Memantine (10 mg/d for 15 days)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 33152448

Group type: EXPERIMENTAL
Intervention: 18 doses of 40 mg/m2 of prednisone on alternate days (short arm)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Cumulative dose of prednisone tapered over double the time (long arm)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Overall relapse rate for both arms
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Post-hoc analysis excluding 30 patients treated with low-dose prednisone maintenance therapy
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Adverse events, blood pressure, and weight gain
Number of subjects: 78
Study: 32216730

Group type: EXPERIMENTAL
Intervention: 60 Gy (over 6 weeks) with cisplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: 60 Gy (over 5 weeks) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 70 Gy plus cisplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: cetuximab
Number of subjects: 0
Study: 35622854

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (500,000 IU single oral dose)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study: 34352415

Group type: EXPERIMENTAL
Intervention: Anger Management Program
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 43
Study: 32187881

Group type: EXPERIMENTAL
Intervention: Licogliflozin 50 mg twice daily
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Licogliflozin 150 mg once daily
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 34837648

Group type: EXPERIMENTAL
Intervention: Low-dose dexamethasone (8 mg once daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intermediate-dose dexamethasone (8 mg twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose dexamethasone (8 mg thrice daily)
Number of subjects: 0
Study: 36345013

Group type: EXPERIMENTAL
Intervention: Hydrocortisone treatment
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 35353960

Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 1181

Group type: COMPARATOR
Intervention: Control plasma
Number of subjects: 1181
Study: 34708640

Group type: EXPERIMENTAL
Intervention: Integrated Traditional Chinese and Western Medicine
Number of subjects: 860

Group type: COMPARATOR
Intervention: Control group treated according to Western Medicine guidelines
Number of subjects: 860
Study: 32186587

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC) Oxygen Therapy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional Oxygen Therapy
Number of subjects: 65
Study: 34887325

Group type: EXPERIMENTAL
Intervention: High-dose prednisolone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-dose prednisolone
Number of subjects: 0
Study: 33609072

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg once daily)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study: 32742520

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy individuals (control group)
Number of subjects: 0
Study: 35813251

Group type: EXPERIMENTAL
Intervention: Enzalutamide (ENZ)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Abiraterone plus Prednisolone (ABI)
Number of subjects: 203
Study: 32639389

Group type: EXPERIMENTAL
Intervention: Low-dose dexmedetomidine 0.2 μg·kg‐1 (group LD)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High-dose dexmedetomidine 0.5 μg·kg‐1 (group HD)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (normal saline, group P)
Number of subjects: 90
Study: 32971163

Group type: EXPERIMENTAL
Intervention: Myrrh extract sitz-bath (10-min, twice a day for 1 week)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Frankincense extract sitz-bath (10-min, twice a day for 1 week)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Betadine sitz-bath (10-min, twice a day for 1 week)
Number of subjects: 90
Study: 32020410

Group type: EXPERIMENTAL
Intervention: Men with elevated ApoB levels
Number of subjects: 182

Group type: COMPARATOR
Intervention: Women with elevated ApoB levels
Number of subjects: 182
Study: 35084881

Group type: EXPERIMENTAL
Intervention: Video-feedback Intervention to promote Positive Parenting and Sensitive Discipline (VIPP-SD)
Number of subjects: 514
Study: 33505154

Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus plantarum Dad‐13 powder (2 × 10^9 CFU/gram/sachet) for 90 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus plantarum Dad‐13 powder
Number of subjects: 60

Group type: COMPARATOR
Intervention: Probiotic Lactobacillus plantarum Dad‐13 powder and Placebo
Number of subjects: 60